89Zr-TLX250 for PET/CT Imaging of ccRCC- ZIRCON Study
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Andrew Scott, MD
Olivia Newton John Cancer Research Center, Austin Hospital
Principal Investigator - Bulent Akdogan, MD
Ankara Hacettepe University
Principal Investigator - Bulent Onal, MD
Istanbul University - Cerrahpasa
Principal Investigator - Carlos Artigas Guix, MD
Instutit Jules Bordet
Principal Investigator - David Chan
Royal North Shore Hospital
Principal Investigator - Declan Murphy, MD
Victorian Comprehensive Cancer Centre
Principal Investigator - Francoise Brodere, MD
University Hospital ICO, Nantes, France
Principal Investigator - Howard Gurney, MD
Macquarie University Hospital
Principal Investigator - Jean-Christophe Bernhard, MD
CHU de Bordeaux, Groupe Hospitalier Pellegrin
Principal Investigator - Karolien Goffin, MD
Universitair Ziekenhuis Leuven
Principal Investigator - Linda Heijmen, MD
Leiden University Medical Centre
Principal Investigator - Marcel Stokkel, MD
The Netherlands Cancer Institute
Principal Investigator - Mark Frydenberg, MD
Cabrini Hospital
Principal Investigator - Martin Geert Steffens, MD
Isala
Principal Investigator - Nicolas Lumen, MD
University Ghent
Principal Investigator - Peter Mulders, MD
Radboud University Medical Center
Principal Investigator - Pierre Olivier, MD
CHRU de Nancy - Hôpitaux de Brabois
Principal Investigator - Simon Wood, MD
Princess Alexander Hospital
Principal Investigator - Sumer Baltaci, MD
Ankara University
Principal Investigator - Tamer Aksoy, MD
Istanbul Training and Research Hospital
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
31 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Royal North Shore Hospital
St Leonards, New South Wales, Australia
- Macquarie University Hospital
Sydney, New South Wales, Australia
- Royal Brisbane and Women'S Hospital
Herston, Queensland, Australia
- Princess Alexandra Hospital
Woolloongabba, Queensland, Australia
- Austin Health
Heidelberg, Victoria, Australia
- Cabrini Hospital
Melbourne, Victoria, Australia
- Victorian Comprehensive Cancer Centre
Melbourne, Victoria, Australia
- Institute Jules Bordet
Brussels, Belgium
- University Hospital Leuven (uz Leuven)
Leuven, Belgium
- Centre de Recherche Centre Hospitalier de L/universite de Montreal (crchum )
Montreal, Quebec, Canada
- Jewish General Hopsital
Montreal, Quebec, Canada
- Chu de Québec - Université Laval - L'Hôtel-Dieu de Québec
Québec, Canada
- Chu de Bordeaux, Groupe Hospitalier Pellegrin
Bordeaux, France
- Chru de Nancy, Hopitaux de Brabois
Nancy, France
- Nantes University Hospital Hotel-Dieu
Nantes, France
- Netherlands Cancer Institute
Amsterdam, Netherlands
- Radboud University Medical Centre
Nijmegen, Netherlands
- Ankara University Medical Faculty Hospital
Ankara, Turkey (Türkiye)
- Hacettepe University Faculty of Medicine
Ankara, Turkey (Türkiye)
- Istanbul Training and Research Hospital
Istanbul, Turkey (Türkiye)
- Istanbul University Cerrahpasa Medical Faculty
Istanbul, Turkey (Türkiye)
- Royal Free London Nhs Foundation Trust
London, United Kingdom
- City of Hope Comprehensive Cancer Center
Duarte, California, United States
- University of California, Los Angeles Campus,
Los Angeles, California, United States
- Emory University
Atlanta, Georgia, United States
- Johns Hopkins University Hospital
Baltimore, Maryland, United States
- Advanced Molecular Imaging & Therapy, Llc
Glen Burnie, Maryland, United States
- Barbara Ann Karmanos Cancer Hospital
Detroit, Michigan, United States
- Washington University St Louis
St Louis, Missouri, United States
- Memorial Sloan Kettering Cancer Center
New York, New York, United States
- Seattle Cancer Care Alliance, University of Washington
Seattle, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 15 Aug 2019
- Primary completion
- 20 Oct 2022
- Completion
- 7 Nov 2022
- Last update posted
- 17 May 2024
- Registered enrollment
- 300
- Registry id
- NCT03849118
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.